» Articles » PMID: 25170297

P Wave Dispersion and QT Dispersion in Adult Turkish Migrants with Familial Mediterranean Fever Living in Germany

Overview
Journal Int J Med Sci
Specialty General Medicine
Date 2014 Aug 30
PMID 25170297
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Familial Mediterranean Fever (FMF) is a hereditary autoinflammatory disease associated with subclinical inflammation, which includes atherosclerosis arising from endothelial inflammation, which in turn increases the risk of atrial or ventricular arrhythmias. Conduction abnormalities can be detected using the electrocardiographic (ECG) indices P and QT dispersion (Pdisp and QTdisp). Currently, it is unknown whether patients with FMF are more likely to have abnormalities of these ECG indices. Moreover, existing studies were conducted in countries with higher FMF prevalence. We therefore perform the first prospective study assessing Pdisp and QTdisp in adult FMF patients in Germany, where prevalence of FMF is low.

Method: Asymptomatic FMF patients (n=30) of Turkish ancestry living in Germany and age-matched healthy controls (n=37) were prospectively assessed using 12-lead ECG.

Results: Patients and controls were comparable in gender and body mass index, and patients had higher erythrocyte sedimentation rate (ESR), C-reactive protein (CRP) and serum amyloid A (SAA) compared to controls (ESR: 23.7±14.3 vs. 16.1±13,3 mm/1(st)h, p=0.03, CRP: 0.73±0.9 vs. 0.26±0.4 g/dl, p=0.01, SAA: 3.14±4,8 vs. 0.37±0.3 mg/dl, p<0.01). No statistically significant difference between patients and controls respectively, for Pdisp (43.7±11.9 vs. 47.1±11.2ms, p=0.23), QTdisp (65.9±12.3 vs. 67.6±12.7 ms, p=0.58) or corrected QTdisp (cQTdisp: 73.9±15.0 vs. 76.0±13.3 ms, p=0.55) was found. No correlation could be found between Pdisp or QTdisp or cQTdisp and any of the biochemical markers of inflammation.

Conclusion: FMF patients living in Germany show a Pdisp and QTdisp comparable to healthy controls, with no increased risk of atrial or ventricular arrhythmias indicated.

Citing Articles

The potential role of serum amyloid A as biomarker of rheumatic diseases: a systematic review and meta-analysis.

Zinellu A, Mangoni A Clin Exp Med. 2024; 24(1):141.

PMID: 38951267 PMC: 11217051. DOI: 10.1007/s10238-024-01413-0.


Cardiovascular manifestations of monogenic periodic fever syndromes.

Sonmez H, Bayindir Y, Batu E Clin Rheumatol. 2023; 42(10):2717-2732.

PMID: 36622520 DOI: 10.1007/s10067-023-06504-z.


Relation Between Familial Mediterranean Fever and QT Markers (QTc, QTd, and QTcd): A Systematic Review and Meta-Analysis.

Motawea K, El-Sakka A, Kandil O, Ahmed N, Abdelnaem M, Zaki B Cureus. 2022; 14(10):e30585.

PMID: 36420231 PMC: 9678238. DOI: 10.7759/cureus.30585.


Assessment of myocardial repolarisation parameters in patients with familial Mediterranean fever.

Karaman K, Karayakali M, Erken E, Demirtas A, Ozturk M, Altunkas F Cardiovasc J Afr. 2017; 28(3):154-158.

PMID: 28759086 PMC: 5558142. DOI: 10.5830/CVJA-2016-074.

References
1.
GOLDFINGER S . Colchicine for familial Mediterranean fever. N Engl J Med. 1972; 287(25):1302. DOI: 10.1056/NEJM197212212872514. View

2.
Lachmann H, Sengul B, Yavuzsen T, Booth D, Booth S, Bybee A . Clinical and subclinical inflammation in patients with familial Mediterranean fever and in heterozygous carriers of MEFV mutations. Rheumatology (Oxford). 2006; 45(6):746-50. DOI: 10.1093/rheumatology/kei279. View

3.
Livneh A, Balow Jr J, Pras E, Kastner D, Pras M, Langevitz P . Clinical differences between North African and Iraqi Jews with familial Mediterranean fever. Am J Med Genet. 1998; 75(2):216-9. DOI: 10.1002/(sici)1096-8628(19980113)75:2<216::aid-ajmg20>3.0.co;2-r. View

4.
Kallinich T, Haffner D, Niehues T, Huss K, Lainka E, Neudorf U . Colchicine use in children and adolescents with familial Mediterranean fever: literature review and consensus statement. Pediatrics. 2007; 119(2):e474-83. DOI: 10.1542/peds.2006-1434. View

5.
Aytemir K, Ozer N, Atalar E, Sade E, Aksoyek S, Ovunc K . P wave dispersion on 12-lead electrocardiography in patients with paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 2000; 23(7):1109-12. DOI: 10.1111/j.1540-8159.2000.tb00910.x. View